Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Authors: Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, Wim H.J. Kruit, Jeremy Marsden, Cornelis J.A. Punt, François Salès, Martin Gore, Rona M. MacKie, Zvonko Kusić, Reinhard Dummer, Axel Hauschild, E. Musat, Alan Spatz, Ulrich Keilholz - The Lancet 2008 cited by 642